Amsacrine isethionate
Based on 8 publication(s) in Google Scholar
Amsacrine isethionate (m-AMSA isethionate) is a Topoisomerase II inhibitor. Amsacrine isethionate intercalates into DNA. Amsacrine isethionate induces Ca2+-mediated inactivation of ERK, and also downregulates AKT, promoting MCL1 downregulation mediated by GSK3β via reducing the phosphorylation level of GSK3β. Amsacrine isethionate induces Apoptosis by activating Caspase-9 and Caspase-3. Amsacrine isethionate blocks HERG potassium channels in the open/inactivated state. Amsacrine isethionate induces chromosomal aberrations and sister chromatid exchanges, and inhibits the synthesis of RNA and DNA. Amsacrine isethionate exhibits anti-leukemic activity. Amsacrine isethionate causes cardiac repolarization disorders, QT interval prolongation, ventricular arrhythmias, and increases the risk of sudden cardiac death. Amsacrine isethionate can be used in research related to acute myeloid leukemia, lymphoma and progressive malignancies.
For research use only. We do not sell to patients.
- CAS No.: 80277-14-1
- Formula: C23H25N3O7S2
- Molecular Weight:519.59
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Amsacrine isethionate
More- Cell Metab. 2022 Mar 1;34(3):424-440.e7. [Abstract]
- J Adv Res. 2024 Apr:58:117-128. [Abstract]
- ACS Environ Au. 2025 Aug 5;5(6):573-582. [Abstract]
- Anal Chem. 2025 Jun 3;97(21):11099-11109. [Abstract]
- J Mol Med (Berl). 2019 Aug;97(8):1183-1193. [Abstract]
- Nucleic Acid Ther. 2023 Aug;33(4):248-264. [Abstract]
- University of Colorado Denver. 2024.
- bioRxiv. September 29, 2021.
All Topoisomerase Isoforms
MoreAll DNA/RNA Synthesis Isoforms
MoreAll Caspase Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
Topoisomerase-2 |
GSK-3β |
MCL1 |
Caspase 9 |
Caspase 3 |
In Vitro
Amsacrine (1 μM; 4 h) isethionate induces downregulation of phosphorylated and total AKT in acute myeloid leukemia U937 cells via a proteasome-dependent pathway, and this effect is abolished by pretreatment with MG132 (5 μM; 1 h)[1].
Amsacrine (0.01-100 μM) isethionate potently blocks wild-type HERG potassium channels heterologously expressed in Xenopus oocytes, with an IC50 of 2.0 μM, and exhibits partial reversibility after washout[2].
The inhibitory effect of Amsacrine (10 μM) isethionate on HERG potassium channels heterologously expressed in Xenopus oocytes is attenuated in the HERGY652A mutant, and completely abolished in the HERGF656A and HERGY652A/F656A mutants, indicating that this effect depends on the aromatic residues in the S6 segment of the pore region[2].
Isethionate salt of Amsacrine (at different concentrations; perfused to achieve steady-state block) potently blocks wild-type HERG potassium channels stably expressed in 293 cells, with an IC50 of 209.4 nM[2].
Amsacrine isethionate induces chromosome aberrations, sister chromatid exchanges and micronucleus formation in vitro in a variety of mammalian cells[3].
Amsacrine (0.005-0.25 μg/mL) isethionate induces a dose-dependent increase in chromosome aberrations and sister chromatid exchanges in cultured normal peripheral blood lymphocytes in vitro, with 0.005 μg/mL increasing SCE by 1.5-fold and 0.25 μg/mL increasing SCE by 12-fold[4].
Amsacrine (5.0 μg/mL; 36 h) isethionate inhibits 80% of RNA synthesis and 60% of DNA synthesis in cultured human peripheral blood lymphocytes in vitro, and exerts no significant effect on protein synthesis after 36 h of incubation[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:U937 cells
-
Concentration:1 μM (amsacrine treatment); 5 μM (MG132 pretreatment)
-
Incubation Time:4 h (amsacrine treatment); 1 h (MG132 pretreatment)
-
Result:Induced down-regulation of phosphorylated and total AKT protein levels.
Increased AKT protein turnover.
Was completely blocked by MG132 pretreatment, which restored phosphorylated and total AKT protein levels to near control levels.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:white Swiss albino (male, 10-14 weeks old, 25-30 g)[3]
-
Dosage:0.5 mg/kg; 1.5 mg/kg; 4.5 mg/kg; 6 mg/kg; 9 mg/kg; 12 mg/kg
-
Administration:i.p.; single dose
-
Result:Did not significantly increase micronucleated polychromatic erythrocyte (%MNPCE) frequency compared to controls at 0.5, 1.5, 4.5, and 6 mg/kg doses at 24 hours post-treatment.
Caused a %MNPCE of 0.58 and reduced %PCE to 43.20 at 9 mg/kg dose at 24 hours post-treatment (P < 0.05).
Caused a %MNPCE of 0.92 and reduced %PCE to 39.80 at 12 mg/kg dose at 24 hours post-treatment (P < 0.01).
Did not significantly increase %MNPCE frequency compared to controls at 0.5, 1.5, 4.5, and 6 mg/kg doses at 30 hours post-treatment.
Caused a %MNPCE of 0.68 and reduced %PCE to 42.60 at 9 mg/kg dose at 30 hours post-treatment (P < 0.05).
Caused a %MNPCE of 0.98 and reduced %PCE to 37.00 at 12 mg/kg dose at 30 hours post-treatment (P < 0.01).
Showed 69.38% of micronuclei were centromere-negative (clastogenic effect), with 24.38% having no signal and 45% having only telomere signals, and 30.62% were centromere-positive (aneugenic effect) at 12 mg/kg dose.
Chemical Information
-
CAS No. 80277-14-1
-
Molecular Weight 519.59
-
Formula C23H25N3O7S2
-
SMILES
O=S(O)(CCO)=O.O=S(NC1=CC=C(C(OC)=C1)NC2=C3C=CC=CC3=NC4=C2C=CC=C4)(C)=O
-
Synonyms
m-AMSA isethionate; Acridinyl anisidide isethionate
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (8)
-
Journal Impact Factor
-
Most Recent
-
Cell Metab
Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry. [Abstract]2022 Mar 1;34(3):424-440.e7. PMID: 35150639 -
J Adv Res
Postantibiotic leukocyte enhancement-mediated reduction of intracellular bacteria by macrophages. [Abstract]2024 Apr:58:117-128. PMID: 37290606 -
ACS Environ Au
Machine Learning-Assisted Recognition of Environmental Sulfur-Containing Chemicals in Nontargeted Mass Spectrometry Analysis of Inadequate Mass Resolution. [Abstract]2025 Aug 5;5(6):573-582. PMID: 41277996 -
Anal Chem
Exposome-Scale Investigation of Cl-/Br-Containing Chemicals Using High-Resolution Mass Spectrometry, Multistage Machine Learning, and Cloud Computing. [Abstract]2025 Jun 3;97(21):11099-11109. PMID: 40401576 -
J Mol Med (Berl)
2019 Aug;97(8):1183-1193. PMID: 31201471 -
Nucleic Acid Ther
Mammalian Target of Rapamycin Inhibition Enhances Delivery and Activity of Antisense Oligonucleotides in Uveal Melanoma Cells. [Abstract]2023 Aug;33(4):248-264. PMID: 37389884 -
-
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Ca2+ Staining Technique
Ca2+ staining is an experimental technique that utilizes specific fluorescent probes (such as Fluo-4 AM, Fura-2, etc.) to qualitatively or quantitatively detect dynamic changes in intracellular Ca2+ concentrations; this is achieved by monitoring the changes in fluorescent signals generated when these probes bind to free intracellular calcium ions. The underlying principle relies primarily on the presence of chelating groups within the probe's molecular structure that possess high affinity for calcium ions.
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
Purity & Documentation
References
[1]. Lee YC, et al. Amsacrine-induced apoptosis of human leukemia U937 cells is mediated by the inhibition of AKT- and ERK-induced stabilization of MCL1. Apoptosis : an international journal on programmed cell death. 2017 Mar;22(3):406-420. [Content Brief]
[2]. Thomas D, et al. Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of action. British journal of pharmacology. 2004 Jun;142(3):485-94. [Content Brief]
[3]. Attia SM. Molecular cytogenetic evaluation of the mechanism of genotoxic potential of amsacrine and nocodazole in mouse bone marrow cells. Journal of applied toxicology : JAT. 2013 Jun;33(6):426-33. [Content Brief]
[4]. Kao-Shan CS, et al. Cytogenetic effects of amsacrine on human lymphocytes in vivo and in vitro. Cancer treatment reports. 1984;68(7-8):989-97. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)